More on Mako Surgical Corp (NASDAQ:MAKO): Q2 EPS loss beats by a penny on revenue in line with estimates. Total revenue jumped over 27% on higher systems sales and procedures. Over 2,590 MAKOplasty procedures were performed in the second quarter, a 66% increase over the same period in 2011. Shares +4.5% AH.